Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns the liver into a short‑lived factory for powerful T‑cell survival signals.

Researchers at MIT have unveiled a way to coax an aging immune system into acting young again, using the same kind of mRNA technology that powered the first COVID-19 vaccines. Instead of trying to ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More MIT scientists have developed a deep learning system, Air-Guardian, ...